Published in Pharma Investments, Ventures and Law Weekly, November 19th, 2006
The Acorda sales team promotes Zanaflex Capsules (tizanidine hydrochloride).
"This second expansion will allow us to reach a much greater number of specialists with increased frequency and efficiency," said John Librie, VP, Sales and Marketing. "In addition, the Acorda team will be able to address the primary care market opportunity."
The current sales force of 32 people, including 25 area business managers, has an average of 15...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.